| Category | Details |
|---|---|
| Product Name & IUPAC Name |
Product Name: 4,6-Dichloropyrimidine IUPAC Name: 4,6-dichloropyrimidine |
| Chemical Formula | C4H2Cl2N2 |
| Synonyms & Trade Names |
Production teams typically reference the following: 4,6-Dichloro-1,3-diazine; 4,6-Dichloro-pyrimidine. Trade names or internal designations are determined by customer specification, supply chain integration, or internal batch labelling as required by downstream applications (pharmaceutical, agrochemical, or materials sectors). |
| HS Code & Customs Classification |
HS Code selection aligns with harmonized customs regulations for pyrimidine derivatives containing halogen substituents. In most production and export operations, this compound falls under HS Code: 2933.59 (heterocyclic compounds with nitrogen hetero-atom(s) only; more specifically: pyrimidine and derivatives). Exact customs classification depends on regional interpretations, downstream customs legislation, and confirmation with local authorities for each shipment. Documentation teams verify the product description and intended use to avoid regulatory discrepancies. |
In our manufacturing environment, decisions about sourcing and product routing for 4,6-dichloropyrimidine revolve around batch-to-batch reproducibility and feedstock integrity. Raw material selection depends on the required degree of chlorination and the intended downstream transformation: either for pharmaceutical intermediates or crop protection active ingredient synthesis. Each application segment demands tailored impurity profiling and control due to differing regulatory and quality protocols. Consistent batch output hinges on careful management of chlorinating agents, solvent selection, and temperature profile during dichlorination. Routine in-process checks track exothermic response, color formation, and chlorinated byproduct emergence. Production maintains strict isolation points to differentiate technical from high-purity grades.
Release into the market is contingent upon analytical review for isomeric content, chlorine distribution, and pyrimidine backbone integrity. Typical values and risk controls shift according to the order specification. In agrochemical channels, higher tolerance for certain low-level isomeric chlorides may be permitted based on toxicological review, while pharmaceutical routes require far tighter impurity release criteria. Inventory and storage teams factor in reactivity with common packaging lines: chlorinated pyrimidines are sensitive to moisture ingress and require inert atmosphere controls in sensitive distribution chains.
For international trade, the declared HS code must match both inward and outward customs flows with necessary supporting documents. Documentation and logistics teams work with on-site regulatory experts to pre-clear classification under 2933.59, with further specification depending on the country of entry, to streamline clearance and minimize transit delays. Grade assignment, shelf-life discussions, and material transfer details are standardized through internal release protocols, never abstracted or generalized but instead substantiated by specific batch release analytics.
Industrial batches of 4,6-dichloropyrimidine typically present as a crystalline solid. Appearance shows moderate variation according to purity and grade, with color shifting from off-white to pale yellow as impurity content or storage duration increases. Odor, while not pronounced, can intensify with certain volatile byproducts emerging from non-optimized synthesis or prolonged storage. Melting and boiling points are sensitive to purity, with technical grades showing mild depression due to residual chlorinated or pyrimidine-based contaminants. Consistent form is essential for downstream formulation; any deviation signals the need for in-process review.
4,6-dichloropyrimidine exhibits hydrolytic sensitivity, especially in presence of moisture or elevated temperature. Stability directly ties to water content during production, packaging integrity, and the avoidance of nucleophilic environments. Batch age and exposure to light accelerate degradation, underscoring the importance of maintenance of protective atmosphere and appropriate storage temperature within the facility and downstream logistics. Reactivity with bases, strong nucleophiles, and certain transition-metal catalysts defines both utility and necessary caution points in plant handling.
Solubility profile fluctuates across grades and is highly solvent-dependent: common polar aprotic solvents (such as DMF, DMSO) are routinely used for solution preparation. Residual moisture in the crystal structure impacts solubility behavior and solution clarity, informing our in-process drying and analytical controls. Solubility is a critical parameter during both synthesis and downstream amination or cross-coupling applications, requiring regular checks for batch-to-batch consistency and suitability for specific end-user solvent systems.
| Property | Technical Grade | High Purity Grade |
|---|---|---|
| Appearance | Pale yellow to off-white solid | Off-white crystalline solid |
| Assay (by HPLC/GC) | Grade-specific, customer-defined | Batch-defined, generally higher |
| Major Impurities (total) | Process and raw-material dependent | Tighter impurity limits, defined by specification |
| Water Content | Monitored, impacts handling and stability | Tightly controlled |
Specifications differ significantly for pharmaceutical, agrochemical, and research markets. Assay and impurity limits reflect process, raw material source, and customer requirement. Our specifications reflect validated process capabilities and analytical control.
Principal impurities are mono-chlorinated or non-chlorinated pyrimidine derivatives, residual starting materials, and hydrolysis byproducts. Impurity spectrum shifts with raw material source and batch scale. Limits are set based on internal process control data and, for regulated applications, customer and regulatory specifications. Analytical approaches (HPLC, GC, NMR) are selected for impurity identity and content quantification, and their scope is redefined for each customer-specific or regulatory-driven scenario.
Assay and impurity determination relies on validated methods calibrated with certified reference materials. Each grade requires a specific analytical approach, defined during process validation and adjusted as process improvements are introduced. Ongoing alignment with latest analytical standards is maintained through regular review and cross-laboratory studies for reproducibility.
Raw materials include high-purity pyrimidine and chlorinating agents. Source qualification adheres to internal standards designed to mitigate variability and secure batch consistency. Sourcing decision considers not only purity but also reactivity profile, moisture content, and trace metal contaminants, due to their downstream reactivity or potential to form persistent impurities.
Standard process applies direct chlorination of pyrimidine under controlled conditions, optimizing for selectivity at the 4 and 6 positions. Chlorine source, catalyst choice, solvent selection, and temperature profile drive yield, impurity pattern, and downstream refinement steps. The process is frequently optimized for raw material cost, ease of purification, and environmental profile based on manufacturing region.
Chlorination reactions are closely monitored for temperature excursion, gas-phase contaminant levels, and extent of conversion. Purification involves staged solvent extractions, distillation, and filtration. All intermediate and final stages undergo inline and offline analytics for impurity cut-off and assay verification. Any deviation triggers a process investigation to identify root cause and corrective action at the batch or system level.
Each lot must meet in-house release specs based on process validation data and customer application. Parameters such as crystal habit, color index, residual solvent, and impurity fingerprint are compared with historical data. Release incorporates retention of analytical samples for traceability. Customer-specific protocols can layer on additional requirements.
4,6-dichloropyrimidine acts as a bifunctional electrophile in nucleophilic aromatic substitution, especially for the synthesis of heterocyclic intermediates in pharma and crop protection. Reactivity at the 4- and 6- positions is influenced by reaction medium, catalyst presence, and temperature, affecting the selectivity towards mono- or di-substituted derivatives.
Industrial processes commonly employ strong bases, polar aprotic solvents, and variable temperature regimes, depending on the nucleophile and final product requirements. Reaction conditions must be managed closely to favor targeted regioselectivity and prevent side-product build-up, with solvent and catalyst selection tightly linked to the desired product profile and downstream isolation process.
Modification potential includes introduction of amino, alkoxy, or aryl groups at the 4 and/or 6 positions. The scope of downstream products spans APIs, intermediates, and specialty compounds, dictated by the capability to control substitution pattern and minimize undesired byproducts.
Product stability varies with storage conditions. Recommended storage involves a cool, dry, and inert atmosphere—preferably nitrogen—using UV-opaque containers. High humidity, elevated temperature, or exposure to air accelerates hydrolytic and photolytic degradation, measurable by color and purity changes. Storage in lined steel or compatible high-density polyethylene is standard.
Containers must resist chlorine-induced stress-cracking and not leach volatile organics into product. Batch migration studies are periodically conducted as part of ongoing quality assurance.
Defined shelf life depends on grade, container system, and storage conditions. Degradation signs include color darkening, increased moisture content, and appearance of hydrolytic impurities, all detectable via standard analytical techniques and prompting reevaluation or reprocessing.
The product receives a classification based on current GHS criteria, with updates as regulatory standards evolve. Labeling reflects acute toxicity via inhalation, skin and eye irritation, and environmental hazard profile established via toxicological and ecotoxicological studies.
Our departments underline the potential for respiratory, dermal, and ocular exposure during handling. Precautionary approach calls for mechanical ventilation, personal protective equipment (respirator, gloves, goggles), and rigorous containment in process areas. Procedures define decontamination and emergency response, tailored to site-specific risk mapping.
Available data indicate acute toxicity concerns for inhalation and dermal exposure above certain limits. Chronic exposure data continues to evolve as regional regulations and new studies emerge. LD50 and related figures, where determined, inform the threshold limit values used internally and in product labeling.
Plant environment and downstream users follow strict exposure control, including air monitoring and sealed process steps. Training and PPE selection reflect updated toxicological assessments and material safety data. Handling protocols benchmark against industry practices for chlorinated aromatic heterocycles, regularly re-examined as workplace safety research advances.
As a producer specializing in chlorinated pyrimidines, we maintain multi-reactor systems aligned with batch scheduling driven by actual customer contracts and projected industrial growth in pharmaceutical and agrochemical sectors. Installed production capacity is engineered for demand surges, but actual availability is batch-dependent, with output rates influenced strongly by grade requirements (pharma vs technical), solvent recovery, and in-process bottlenecks.
Standard lead time ranges from several weeks for technical grade to extended periods for customer-specific high-purity or regulatory-critical lots. MOQ is contractually set based on grade, packaging variant, and risk exposure in storage and logistics—lower for regular technical customers, higher for custom or regulated international orders.
Grade influences packaging: corrosion-resistant, UN-certified drums for export, sealed HDPE or fiber drums for domestic use, and custom lining or small-batch splits for pilot and R&D requirements, always matching the downstream process and handling constraints. Packaging choice impacts logistical planning and total landed cost per kilogram.
Export shipments comply with IMDG/ADR for hazardous cargo when necessary, with main lanes routed via approved forwarders. Payment terms reflect partner status, credit evaluation, and jurisdiction-specific currency risk—FOB, CIF, and DAP terms prevail, adjusted for contract volume and tenure.
Cost structure pivots on chlorination agents, precursor pyrimidine costs often indexed to upstream petrochemical and ammonia markets, and utilities required for distillation and purification. Waste treatment and byproduct recycling add to operational outlay during tight environmental inspections.
Feedstock volatility remains the major driver. Global price swings in chlorinating reagents and basic aromatic/nitrogen feedstocks translate into immediate cost shifts in production. Seasonal inventory runs by large pharma groups and regulatory audits, particularly in high-demand quarters, tighten supply margins and prompt rapid price reactions.
Pricing reflects strictly enforced grade differentiation: technical, intermediate, and pharmaceutical grades diverge both in released impurity profiles and documentation burden. Certification, particularly for GMP or FSSC-regulated supply, pushes up cost due to mandatory analytical release, enhanced traceability, and third-party auditing overhead.
Grade and purity directly set lifecycle costs by dictating control points, purification intensity, and analytical coverage. Higher purity requires more solvent-intensive processes, tighter rejection criteria, and additional fractional crystallization or distillation. Certification (ISO, GMP, or regionally specific registrations) multiplies batch-release effort and narrows usable output per run. Packaging with UN certification or customized labeling adds an incremental but non-negligible surcharge, especially for hazardous goods compliance.
Bulk production centers cluster in East Asia, backed by integrated chlorination routes and access to low-cost precursors. Mature regulations in the US, EU, and Japan restrict local supplier pools but uphold documented traceability and continuous compliance, leading transnational buyers to segment their source preference according to registration status and end-use audit requirements. India emerges as a major secondary supplier with rising pharmaceutical intermediate demand but faces episodic supply interruptions driven by regulatory spot checks and shifting taxation.
Forecasting locks onto projected growth in global insecticide and active pharmaceutical ingredient output. Price trends are likely to reflect continuing upstream raw material volatility, while diverging grades and tightening global compliance inflate premium grade prices. Endpoint pricing depends on sustained compliance costs, logistics inflation, and regional regulatory harmonization outcomes. Expected upward price pressure in high purity and certified lots; basic technical grades remain priced by bulk raw material indices unless environmental levies increase operational overhead.
Analysis uses year-on-year contract pricing, major port customs data, feedstock price indices (petrochemicals, chlorinating agents), and on-ground intelligence provided by partner production sites, direct customer forecasts, and compliance audit outcomes. Historical volatility helps model price corridors, with scenario planning set by registered plant capacity at principal manufacturing hubs.
Recent quarters showed regional supply constraints tied to mandatory shut-downs for environmental compliance upgrades in key manufacturing zones. Heightened downstream API demand, especially for antiviral intermediates, led to episodes of short-term allocation and prioritized supply for established long-contract buyers.
Tighter import surveillance in established economies driving new documentation requirements for supply chain traceability and impurity profile clarity. Wastewater discharge and secondary handling controls strengthened in most Asian production zones, affecting batch scheduling and total throughput during audit windows.
Producers invested in both analytical infrastructure and real-time batch tracking systems to meet evolving compliance and customer audit expectations. Increased in-house recycling and solvent management programs implemented to offset environmental surcharges. Contracting strategies emphasize multi-quarter rolling orders to buffer feedstock swings and mitigate single-source exposure for regulated grades.
4,6-Dichloropyrimidine remains a core building block in pharmaceutical synthesis, agrochemical intermediates, and material science projects. Our regular industrial contacts focus on three major markets:
| Application Field | Typical Grade(s) | Critical Quality Points |
|---|---|---|
| Pharmaceuticals | API Intermediate / cGMP-Ready / High Purity | Ultra-low organic/inorganic impurities, low moisture, trace metal residue, defined isomer profile, documented impurity pathway, batch-to-batch consistency |
| Agrochemical | Technical / Industrial | Consistent purity profile, process contaminants below regulatory tolerance, scalable lot size, documented physical properties (melting point, solubility profile) |
| Material Chemistry | Specialty / Custom Purity / R&D | Halogen specification, residual solvent profile, defined particle characteristics (for specific formulations), customizable impurity mix |
Stakeholders in synthesis, formulation, or R&D must clearly identify the final application: is it an API intermediate, crop protection agent, or material additive? Production routes and control points change based on how the compound will enter downstream synthesis or formulation. Feedback from prior projects recommends open early consultation with technical support to clarify whether lab, pilot, or manufacturing scale fits the project lifecycle.
Pharma users track cGMP compliance, DMF registration, and traceability. Agrochemical applications often reference REACH, EPA, or national authority guidance for permissible impurity and contaminant limits. Materials sectors sometimes work within voluntary frameworks, but specific commercial clients may set their own in-house supplier audit policies. Reference to the end-use jurisdiction and documentation regime should drive this stage, as batch documentation and change-control are grade-specific.
Target purity stems from both your process chemistry and target product specifications. Pharma R&D and CDMO partners lean toward highest achievable purity and must review individual impurity profiles supplied on COA & batch records; routine technical/industrial applications may relax these windows. Materials projects may emphasize a custom impurity spectrum or physical state. If impurity identity influences downstream synthesis or formulation, share feedback with our technical service for process route input.
Cost, batch size, and delivery approach interact. API and specialty applications require smaller validated lots, sometimes with custom packaging, which involves higher per-unit costs. Technical and industrial users with bulk needs benefit from optimized process scale but must be ready to balance price-per-kilo against purity, moisture content, and residuals. Discussing supply forecasts and seasonal or surge demand helps align internal planning for raw material inventory and production slotting.
We ship technical samples of 4,6-dichloropyrimidine to enable laboratory compatibility, process validation, and method development. Before full-scale adoption, run comparative processing, impurity mapping, and product performance checks per your protocol. Advanced notice on special physical form, packaging, or documentation requests improves turnaround.
Our 4,6-Dichloropyrimidine manufacturing follows documented quality management systems tailored to the requirements of chemical synthesis at an industrial scale. The facility operates under a certified quality framework that covers incoming raw materials, all stages of synthesis, purification, and finished product release. These certifications support traceability, batch documentation, and continuous process verification. Consistent implementation of such systems leads to reproducible product output and streamlined troubleshooting when deviations occur.
Certifications applicable to this intermediate are maintained according to customer segment demand. In regulated markets, documentation aligns with needs for pharmaceutical or agrochemical applications and can include audit-ready manufacturing and process records. For industrial grades, audit support can focus on raw material provenance and impurity control strategies. Actual certification scope and documentation depth will be determined by the end-use sector and grade order.
We issue technical data sheets, certificates of analysis, batch release specifications, and process flow documentation. Each report contains lot-specific values and commentary by our quality and analytical teams. Characterization results typically rely on validated internal standards and third-party verification on request. Custom report formats and release parameter detail may be expanded for special procurement projects, particularly where customer-defined specifications or local regulatory frameworks apply.
Long-term supply commitments rely on a core production line designed around continuous availability of precursor materials and in-house secondary synthesis steps. Production scheduling responds to forecasted and contract-backed demand, with buffering arrangements for both regular supply and surge orders. Output rates and allocation flexibility depend on order volume, seasonality of raw material markets, and customer supply priorities agreed in advance.
Plant capacity planning considers both current output requirements and potential for multi-line scale-up. Batch consistency measures include tight process parameter control, raw material vendor approval, and intermediate sampling at defined stages. Supply chain stability rests on locally sourced key reagents combined with a dual-source policy for critical inputs, reducing exposure to single-point disruptions. Actual shipment and allocation cycles are communicated transparently, with revision protocols in the event of unforeseen market changes.
Customers may request evaluation samples as part of technical project development or qualification runs. Sample shipments are coordinated with a dedicated technical support point of contact who documents specific testing objectives, application details, and customer-specific concerns regarding physical or chemical properties. Sample selection references representative production lots, with accompanying batch documentation to support downstream application testing or regulatory submission needs. Turnaround for supply depends on availability of suitable campaign lots and transporter compliance for hazardous material handling where relevant.
Business cooperation spans fixed-term contracts, open order agreements, and project-based supply frameworks. In project-based support, production cycles and specification adjustment are managed according to customer R&D timelines and feedback. Larger volume contracts may allow for inventory reservation or dynamic drawdown schedules, with pricing and logistics arrangements reflecting risk-sharing between producer and consumer. Where multiple end-use sectors are involved, packaging options and specification variants can be discussed and implemented with appropriate lead times. Key to effective cooperation is direct communication between technical, procurement, and quality management teams on both sides to ensure expectation alignment throughout the supply relationship.
In industrial-scale synthesis of 4,6-dichloropyrimidine, research teams prioritize process optimization for halogenation efficiency and impurity pathway suppression. Process chemists keep a close watch on side product patterns at each halogen exchange stage, especially as most routes use dichlorination of pyrimidine cores with varying chlorine sources and catalysts. Key interests include the development of new catalytic systems and more selective chlorination methods to streamline downstream purification.
The compound’s core structure supports several programs in agrochemical and pharmaceutical intermediate manufacturing. Our technical teams track requests from active ingredient formulators who increasingly seek customization in substitution patterns and minimal legacy solvent residues. The expanding push for complex heterocycle synthesis in drug discovery means synthetic chemists focus on optimization for further nucleophilic substitution, particularly at the 4 and 6 positions. Attachment of specific vector groups for bioconjugation and kinase inhibitor development drives demand for grades with well-characterized impurity profiles and predictable reactivity in secondary functionalization steps.
Most technical hurdles relate to batch reproducibility in large-scale runs, purification of byproducts (notably polychlorinated derivatives), and robust handling of exothermicity during chlorination. Process development chemists commit substantial time mapping impurity formation versus raw material selection, as changes in precursor pyrimidine quality shift the impurity pattern and require tailored purification protocols. Process control teams have made gains using in-line analytical process control for critical reaction stages, which has improved batch-to-batch consistency. Some facilities implement real-time monitoring for chloride ion content to help predict endpoint and facilitate rapid intervention during batch upset events.
Downstream innovation in pesticide and active pharmaceutical ingredient (API) synthesis will sustain moderate growth in demand. Regional trends indicate expansion in Asian and North American chemical hubs, tied to cluster development in specialty intermediates. Seasonality and global production capacity of chloro-pyrimidine derivatives influence buying patterns, requiring adaptive inventory management and agile response to shifts in import-export regulations.
Process improvements focus on energy consumption reduction and byproduct valorization, especially for upgrading dichlorinated residue streams rather than treating them as waste. Facilities with established closed-loop chlorine recovery outperform in resource efficiency. Our engineers continuously test new catalysts and alternative chlorinating agents with an eye on reducing batch cycle time, solvent load, and byproduct salt disposal.
Customer procurement teams request documentation on solvent reuse rates, effluent treatment efficiency, and carbon management strategies. Some production lines have implemented partial solvent recycling, minimizing reliance on virgin halogenated solvents. The business case for greener processes grows as procurement and regulatory teams emphasize demonstrable waste minimization and compliance readiness for future environmental standards.
R&D and production chemists collaborate with customer process teams to address specific chlorination reaction requirements and downstream functionalization preferences. Recommendations for grade selection are based on end-use targets and feedstock compatibility, verified against internal batch release criteria and customer-supplied specifications. Requests for impurity pathway clarification, on-site troubleshooting, and analysis of side product formation get direct support from analytical and process chemists with practical experience in the industrial setting.
Support teams assess actual lab-to-plant transfer performance by gathering and reviewing reaction yield, solvent compatibility, and isolation efficiency data under customer process conditions. Guidance includes safe handling protocols for high-purity and technical grades, with technical documents cross-referencing typical application challenges in pharmaceutical and agrochemical process chemistry. Data from internal scale-up projects inform optimized feeding regimes, heat management and purification steps for customer-specific requirements.
After delivery, quality assurance personnel follow up on performance feedback, monitor all relevant batch deviations, and provide root cause analysis for claims related to unexpected reactivity or impurity occurrence. Customers gain access to archived batch records and analytical datasets to streamline regulatory documentation for their final products. Logistics and product stewardship teams resolve batch-specific transportation or storage inquiries, ensuring product quality aligns with technical documentation throughout its shelf life, as defined per grade and customer requirements.
4,6-Dichloropyrimidine stands among the essential intermediates for pharmaceutical, agrochemical, and specialty material production. Our facility manufactures this compound under controlled conditions based on proprietary routes, scaling from process development through commercial output with measured precision. Every metric ton reflects established protocols, strict impurity limits, and analytical checks aligned with industrial requirements.
Each production batch of 4,6-Dichloropyrimidine leaves our reactors after rigorous in-process monitoring. Inline QC instruments measure residual solvents, trace metals, and byproducts at each critical point. Our technical staff reviews data sets from HPLC, GC, and NMR before approving the material for final isolation. This hands-on approach supports predictable downstream results for customers using 4,6-Dichloropyrimidine as a core building block.
Pharmaceutical process chemists rely on 4,6-Dichloropyrimidine as a starting point for pyrimidine-based drug scaffolds, antiviral and anticancer active ingredients, and contract synthesis campaigns. In agrochemical plants, this compound enters into chlorinated or substituted pyrimidine routes for herbicide actives. Manufacturers of advanced materials integrate this molecule in dyes, pigments, or functional coatings. The connection in all these sectors is straightforward: process efficiency and robust material supply make or break multistep synthesis economics.
Any 4,6-Dichloropyrimidine batch released from our site comes with batch-specific QC documentation, supported by complete analytical archives. Certificate of analysis accompanies every consignment, referencing lot-specific spectral output and impurity profiles. We validate every instrument used for final release under our site’s comprehensive quality manual. For regulated markets, full traceability extends from starting material intake to finished drum shipment, with retention samples kept for post-shipment verification.
Our packing facilities support multiple unit sizes, from lab-scale packs to lined steel drums and intermediate bulk containers. Customers specify labeling conventions and closure requirements suited to their warehouse workflows and material transfer practices. We maintain buffer inventory for standard volumes to ensure short lead times, even for urgent campaigns and large plant runs. Shipments meet international transportation requirements for hazardous goods and preserve product integrity throughout transit.
Process teams often consult with us prior to scale-up or tech transfer, sharing requirements for solubility, filtration behavior, or impurity carryover. Our application chemists review these inquiries, drawing on real plant data to resolve points related to reactivity and process bottlenecks. Experienced personnel provide guidance on dosing, handling, and safe transfer operations, all based on in-house run data instead of theoretical or generic advice. Troubleshooting and process optimization support continue beyond initial supply.
Our continuous investment in robust supply chains, technical infrastructure, and process feedback loops delivers measurable value to manufacturers, procurement managers, and distribution partners. Reduced batch variation enables streamlined plant operations, minimizes regulatory interruption, and controls rework costs. Commercial buyers depend on this track record to forecast logistics, manage inventory, and support their own downstream timelines. Our team stands behind every shipment—traceable, supported, and aligned with industrial growth objectives.
As a producer of 4,6-Dichloropyrimidine, our perspective on the key properties and purity considerations of this intermediate comes from extensive lab, scale-up, and full-batch production experience. The value in a chemical like 4,6-Dichloropyrimidine rests not only in a clean synthesis but in repeatably achieving a tight property profile batch after batch. Our customers rely on it as a building block in pharmaceuticals, agrochemicals, and specialty applications where trace impurities can undermine end-product performance or regulatory acceptance.
4,6-Dichloropyrimidine has a crystalline nature at room temperature, making it manageable for handling, packaging, and downstream processing. The molecular formula is C4H2Cl2N2, and our material typically presents as a pale, off-white solid. High purity produces a sharp melting point—typically in the range of 93–97°C. The melting range, monitored batchwise, functions as a quick check for gross impurities. Solubility in common organic solvents (such as DMSO or dichloromethane) allows for flexibility in various synthesis routes. The compound remains stable under normal storage, provided it is kept in tightly sealed containers protected from moisture, as hydrolysis over long exposures can form unwanted byproducts, including pyrimidinols.
End users in regulated industries expect more than a minimum threshold of chemical purity. For 4,6-Dichloropyrimidine, we define batch purity through rigorous HPLC and NMR analysis—routinely delivering >99% purity material. Residual solvents, heavy metal content, and moisture levels come under tight control, documented in each certificate of analysis. Moisture, in particular, is critical; excess water can trigger slow hydrolysis, generating measurable contamination. We implement Karl Fischer titration to keep moisture well below 0.5% w/w. Heavy metals must remain at trace levels: our finished lots typically register below commonly accepted thresholds for lead, cadmium, or mercury since metal-catalyzed steps or recycled reagents can leave surprising fingerprint levels without robust control.
We also screen for closely related pyrimidine impurities. Chlorinated isomers, incomplete chlorination, or carryover from precursor materials can slip past standard melting point checks. We routinely run LC-MS and GC analysis for volatile and nonvolatile organic by-products. Our technical staff develops in-house reference standards for these profiles, refining methods to detect impurities down to the low ppm level. Each parameter feeds back into our process review and cleaning steps for plant equipment.
Our process deliberately builds in excess chlorination to drive the reaction to completion, followed by carefully staged purification steps. Column chromatography and controlled crystallization bring down impurity loads and narrow melting profiles. Standard packaging—lined fiber drums with vacuum-sealed liner bags—help preserve material characteristics during shipment and warehousing. For custom requests, we offer tailored particle size or granulation profiles to suit flowability or process integration on the customer’s side.
The benchmark for a viable production campaign comes down to reproducible purity, with documented analytical backup and visible attention to off-spec responses. For technical or regulatory filings, we can provide detailed impurity profiles, safety data, and support for scale-up validation. Our engagement doesn't end after shipment; technical representatives provide guidance on storage, repackaging, or troubleshooting unexpected handling issues that might arise. That is the real backbone of quality in the specialty chemicals sector, where experience on the shop floor determines reliability in your formulation lab.
In the manufacturing and large-scale distribution of 4,6-Dichloropyrimidine, bulk buyers place priority on two realities: secure, reliable packaging and realistic lead times. These shape not only project timelines, but also bottom lines in pharmaceutical, agrochemical, and specialty chemical applications. As direct producers, we recognize clients expect straight answers supported by on-the-ground experience rather than scripted templates or speculative statements.
Our facilities accommodate the demand for both intermediate and larger volume procurement. We typically offer 4,6-Dichloropyrimidine in fiber drums (net weight 25 kg), high-integrity polyethylene-lined drums (up to 50 kg net) and, for projects requiring even larger scale, UN-approved intermediate bulk containers (IBCs) in the 500 kg and 1,000 kg range. Custom packaging emerges occasionally for unique logistics requirements or site-specific handling, which we design in direct consultation with the client. Experience reveals that packaging integrity directly influences both product stability and regulatory compliance, especially over longer transit schedules and in fluctuating climates.
Steel or HDPE drums have remained a mainstay for international shipments—these formats support required reactivity controls while meeting solvent and moisture control standards for this dichloro-intermediate. Our technical team regularly inspects packaging lots, calibrating liner thickness and closure design to protect the integrity of each consignment.
Lead time discussions start in our production scheduling room, not a sales handbook. We commit to realistic windows determined by raw material inventories, reactor availability, and the export documentation process. For regular volumes (up to two metric tons), our production cycle—factoring in synthesis, purification, QA/QC, and packing—runs between 3 and 4 weeks from the confirmation of the order and technical agreement. Custom pack sizes, extra certification, or off-cycle orders sometimes require a longer window, especially when the product must satisfy specific impurity thresholds or enhanced traceability documentation.
Procurement teams across pharmaceutical majors and contract manufacturers have pressed us for ever-tighter timelines over the past year, especially as downstream lead times fluctuate in response to changing demand for pyrimidine-based intermediates. Maintaining a buffer inventory has proven essential for clients operating just-in-time models, and we have adjusted our internal batch scheduling to help offset raw material volatility and logistical bottlenecks at shipping ports. Our network of contract logistics partners helps execute time-sensitive international shipments, but we do not lower our QA/QC threshold to accelerate a shipment—product consistency and analytical documentation remain non-negotiable.
Direct engagement with OEMs and multinational formulation facilities has made it clear that surprises kill value on the end-user side. Our commercial and technical teams provide detailed batch histories and supply chain overviews on request, supporting the traceability standards that are increasingly mandated in regulated markets. We document every step in transportation, packing, and analytical release. Where project timing is tight, we involve both factory and project teams to explore expedited packing or staged deliveries.
As manufacturers operating reactors, packaging lines, and QA labs under one roof, we have the flexibility to adjust to the dynamic requirements of strategic partners, provided communication starts early and technical details are fully aligned up front. We stake our reputation on reliability, not generic answers. This approach keeps projects moving and compliance on track, which is what bulk buyers genuinely require from a factory-direct supplier of 4,6-Dichloropyrimidine.
Shipping 4,6-Dichloropyrimidine falls squarely in the category of regulated chemical transport. Our team has handled this compound for years — from drum filling to global shipment. As the manufacturer, we constantly monitor the evolving frameworks put out by international and domestic agencies. Mishandling this material in transit brings immediate regulatory and safety consequences. There is no room for shortcuts or misunderstandings when working with chlorinated heterocycles, especially because of their classification under several hazardous materials codes.
We classify 4,6-Dichloropyrimidine under the appropriate UN number for hazardous goods, which must be stated on all shipping paperwork. The Material Safety Data Sheet (MSDS) and a Declaration of Dangerous Goods document are included with every shipment, and our logistics team verifies accuracy every time. Whether shipping by air, sea, or truck, our documentation package matches requirements of IATA, IMDG, and ADR conventions, reflecting the real-world chemical hazard class and packing group. These declarations are not just regulatory formality — failure to present them brings penalties and puts handlers at risk.
Handling this compound starts right on the production line. We fill only in approved high-density polyethylene or steel drums with certified liners, depending on destination and client protocol. Each drum receives a tamper-evident seal and then undergoes a double-check by experienced supervisors. We do not outsource this work, as chain of custody is critical for any regulated material. Hazard warning labels — featuring the correct UN identifiers and hazard pictograms — are printed using solvent-resistant ink and affixed before shipping to prevent any risk of obscuration in transit.
Many countries require proof of final use or even import permits for substances considered precursors or intermediates in pharmaceutical and agrochemical synthesis. We prepare end-user statements and provide details of chemical structure or intended synthesis pathways as requested by authorities. Our documentation aligns with the chemical control list published in the destination country to avoid border seizure or delay. In all shipments, manifests, hazard declarations, and technical dossiers accompany the cargo physically and electronically. Customs delays usually stem from incomplete or poorly explained paperwork, so we detail every point of origin, batch number, and manufacturing date without cutting corners.
Our staff receives regular hazardous goods handling training. Emergency procedures, spill response, and correct PPE usage are practiced in simulated drills before actual export happens. Compliance officers conduct internal audits before every large-scale shipment, reviewing whether current packaging, paperwork, and routing meet the most current hazardous materials standards. We pass on best practice updates to our distribution partners, so even consignments under Delivered Duty Paid (DDP) reach customers without legal incident.
The path from factory floor to overseas client for 4,6-Dichloropyrimidine carries a network of regulations, not optional guidelines. We have never treated packaging, documentation, and compliance as afterthoughts or marketing buzzwords. Direct manufacturing puts us close to the process, so every shipment we send has already covered regulatory, safety, and practical hurdles. We keep our customers — and the chemical supply chain as a whole — on solid regulatory ground.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales9@alchemist-chem.com, +8615651039172 or WhatsApp: +8615651039172
